Author
Lun–Xiu Qin
Also Known As
L Qin, L. Qin, L.-X. Qin, LUN-XIU QIN, LUNXIU QIN, Lijia Qin, Lingxi Qin, Lun-Xiu QIN, Lun-Xiu Qin, Lun-xiu Qin
365
Publications
21.6K
Citations
76
H-Index
107
Concepts
All Affiliations
| # | Concept | H-Index | Publications | Citations |
|---|---|---|---|---|
1 | Medicine | 42 | 71 | 7.6K |
2 | Health Sciences | 18 | 20 | 2.4K |
3 | Engineering | 1 | 1 | 26 |
4 | Natural Sciences | 1 | 1 | 351 |
5 | Public Health | 1 | 1 | 16 |
Lun–Xiu Qin
×
169
Publications
18.1K
Citations
69
H-Index
| Year | Citations | |
|---|---|---|
2010 | 1.9K | |
2008 | 1.1K | |
2008 | 709 | |
2008 | 700 | |
2011 | 691 | |
Atezolizumab plus bevacizumab versus active surveillance in patients with resected or ablated high-risk hepatocellular carcinoma (IMbrave050): a randomised, open-label, multicentre, phase 3 trial Shukui Qin, Minshan Chen, Ann‐Lii Cheng, Surgical OncologyHepatologyMedicinePathologyHigh-risk Hepatocellular Carcinoma | 2023 | 415 |
2020 | 364 | |
2018 | 351 | |
2011 | 325 | |
2001 | 299 |
Page 1
Page 1